Lamivudine bound in HBV polymerase
SeqHepB is a predictive tool for clinicians in the comprehensive management of the HBV disease, assisting the clinician to make an informed decision as to drug selection based on the mutational and resistance profile of the virus in an individual patient at any given time.
Specifically it:
All material copyright Evivar Medical Pty. Ltd. All rights reserved